Celebrex May Reduce Levels of Lung Cancer... ( Anti-inflammatory might one day help ...)

Celebrex May Reduce Levels of Lung Cancer Biomarker

Date:6/1/2008

Anti-inflammatory might one day help prevent malignancies, study suggests

SUNDAY, June 1 (HealthDay News) -- A widely prescribed pain reliever may one day have value in helping to prevent lung cancer.

Researchers report that Celebrex (celecoxib), the last remaining cox-2 inhibitor on the U.S. market, may reduce levels of a biomarker indicating risk for this deadly disease. The team presented its findings Sunday at the American Society of Clinical Oncology annual meeting in Chicago.

They stressed that this doesn't mean people should start taking the drug for this reason, as Celebrex has noted cardiovascular side effects, albeit effects that were not seen in this short-term study.

"This is a very early study," said Dr. Shakun Malik, director of the lung cancer program at Georgetown's Lombardi Cancer Center, in Washington, D.C. "It hasn't shown any effect on actual lung cancer. All it is showing is that it affects biomarkers. The hypothesis is that if biomarkers are affected, it will help, but we haven't shown that as of yet."

The researchers agreed.

"We cannot sit here and say that taking celecoxib is going to prevent lung cancer," said study author Dr. Edward S. Kim, M.D., an assistant professor of thoracic head and neck medical oncology at the University of Texas M.D. Anderson Cancer Center in Houston. "What we do know was that Celebrex, when taken over a three- or six-month period, was safe to administer even at a higher dose of 800 milligrams daily."

"We certainly need to move forward with prospective validation," added Kim, who spoke at a Sunday news conference. In particular, researchers need to verify if reductions in biomarkers actually translate into a reduction in the risk of developing malignancies in the lung.

"It's too early to tell, but we're definitely interested in other trials to see how they make out with survival,' said Dr. Karen Reckamp, an assistant profe
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Celebrex-Lipitor combo may halt prostate cancer
2. Celebrex Plus Lipitor Could Fight Prostate Cancer
3. Celebrex, Naproxen Wont Prevent Mental Decline
4. Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial
5. New study: Pine bark reduces perimenopausal symptoms
6. Different method of evaluating the urinary tract system reduces radiation dose
7. Saline Reduces Mortality for Brain Injury Patients
8. New approaches to reduce scarring
9. Fruity vegetables and fish reduce asthma and allergies
10. New study: Pine bark extract reduces ADHD symptoms in children
11. New Case Study Details How an Illinois Hospital Created a Safe Lifting Team that Dramatically Reduced Injuries, Increased Staff Satisfaction

Post Your Comments:

(Date:12/16/2009)... NORCROSS, Ga., Dec. 16 Immucor, Inc. (Nasdaq: ... instrument-reagent systems to the blood transfusion industry, today announced ... its board as a new independent director, effective January ... in blood banking and transfusion medicine for more than ... and Medicine at the University of Virginia School of ...

(Date:12/16/2009)... Dec. 16 Losing has never felt so ... maintaining his healthy new lifestyle means continuing to make ... fat free milk is one healthy choice that is ... simple step everyone can take. Every glass of milk ... potassium to help maintain normal blood pressure, and calcium ...

(Date:12/16/2009)... Allscripts (Nasdaq: MDRX ) announced today that ... three and six months ended November 30, 2009 ... 11, 2010. Allscripts management will host a conference ... and other information at 8:30 AM Eastern Standard ... http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, Allscripts fiscal second quarter earnings ...

(Date:12/16/2009)... LAUREL, Md., Dec. 16 For ... Army Medical Center in Washington, D.C., the holidays can ... aren,t able to travel home rely more than ever ... friends. This week, calling home just got easier ... in free calling cards, which will provide hundreds of ...

(Date:12/16/2009)... 16 The most widely used human embryonic stem ... social justice questions that must be addressed to ensure ... advances, according to a University of Michigan research team. ... the U-M team analyzed 47 embryonic stem cell lines, ... cell researchers. The scientists determined the genetic ancestry of ...

Breaking Medicine News(10 mins):Health News:Immucor Appoints New Board Director 2 Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2 Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3 Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4 Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4 Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5

[0] Immucor Appoints New Board Director [0] 'The Biggest Loser' Champ Lives Well With Milk [0] Allscripts to Announce Second Quarter Fiscal 2010 Results [0] Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital [0] U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines

... Ohio Research here shows that an obscure form of ... play an important role in human cancer. , These ... researchers, but a new report in the September issue of ... the case. , The study found that UCRs, like ...

... has rescue workers, medical experts frustrated , , TUESDAY, Sept. ... of the Sept. 11, 2001, World Trade Center disaster ... , First, workers inhaled a toxic cocktail of soot, ... 12-hour shifts that lasted for weeks. There was also ...

... Executive Vice President, Corporate Development and, ... PRINCETON, N.J., Sept. 11 Pharmacopeia,(Nasdaq: ... development of novel,small molecule therapeutics, today announced the ... Corporate Development and S. David,Kimball, Ph.D., as Senior ...

... Vista Partners announced today,that it has updated coverage ... Director of Research for Vista Partners stated, "Tapestry,s,lead ... We were,particularly encouraged by activity in patients with ... for use in this difficult to treat,cancer." Vista ...

... China,Bionanometer Industries Corporation (OTC Pink Sheets: CBIU), a ... a new,series of biological nanometer cosmetics products named ... and experiments. The,name comes from the Italian word ... means -- "One,s Dreams Coming True." The ...

... PORT WASHINGTON, N.Y., Sept. 10 National,Medical Health Card ... benefit manager ("PBM"), today reported its results for the ... Three months ended June 30, 2007 Revenue ... as,compared to revenue of $211.5 million for the same ...

New class of RNA molecules may be important in human cancer 6 Years Later, 9/11 Health Questions Linger Pharmacopeia Announces Senior Additions to Management Team Vista Partners Updates Coverage on Tapestry Pharmaceuticals China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results

(Date:12/16/2009)... 16 According to Millennium Research Group ... intelligence, although the US minimally invasive spinal fusion ... rate of over 12% through 2014, reimbursement concerns ... overall market, which previously had been forecast at ... Minimally Invasive Spine Technologies 2010 ...

(Date:12/16/2009)... Medlytix, a national healthcare consulting firm, reported success ... milestone - the total amount of money that ... to more than a half-million patients nationwide by ... care - in less than two years. ,, ... their bottom lines and still were able to ...

(Date:12/16/2009)... SOLON, Ohio, Dec. 16 HDT Engineered ... next generation technologies and a principal subcontractor for ... (MPL), led development of new anthropromorphic arm technology ... a prosthetic arm and hand, including a sense ... Defense Advanced Research Projects Agency (DARPA) Revolutionizing Prosthetics ...

[0] Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking [0] Healthcare Scoring System Allows Hospitals To Increase Charity Care [0] HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program

... - ZIOPHARM Oncology, Inc.,(NASDAQ: ZIOP) announced today that ... the C.E. Unterberg, Towbin,Emerging Growth Opportunities Conference on ... the Mandarin Oriental Hotel, New York. Dr. Lewis,will ... update on its,clinical development programs., The presentation will ...

... -- Micromet,Inc. , a biopharmaceutical company focusing on ... inflammatory,and autoimmune diseases, today announced that Dr. Christian ... will,present at the 3rd Annual C.E. Unterberg, Towbin ... 12, 2007 at 10:00am,eastern. , A webcast of ...

Other Medicine Technology:ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2 Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin,Emerging Growth Conference 2

ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin,Emerging Growth Conference

Histopathology Reference Laboratory provides a full range of histology services, encompassing routine and specialized grossing, processing, embedding, microtomy, routine and special staining and cove...

PhenoPath Laboratories provides screening, diagnostic, and prognostic testing services to hospitals, physician offices, surgery centers, biopharmaceutical companies and research institutions nationwi...

Headquartered in Burlington, North Carolina, LabCorp has more than 23,500 employees and offers more than 4,400 clinical tests ranging from routine blood analyses to the most sophisticated molecular d...

... The Johns Hopkins University Dermatology, ... Laboratory is a federally-(Clinical Laboratory Improvement ... that began operation in 1982. Its ... quality diagnostic allergy and immunology testing ...

Medicine Products:

Histopathology Reference Laboratory PhenoPath Laboratories LabCorp Dermatology, Allergy and Clinical Immunology (DACI) Reference Laboratory

Celebrex May Reduce Levels of Lung Cancer...( Anti-inflammatory might one day help ...),Health